Lv4
530 积分 2022-11-14 加入
Emerging evidence for sequencing and combining PSMA-based therapies in prostate cancer
6小时前
已完结
Novel Radiopharmaceuticals and Future of Theranostics in Genitourinary Cancers
9天前
已完结
Nuclear Medicine: The Beauty of Theranostics
10天前
已关闭
Overall Survival with Inavolisib in PIK3CA -Mutated Advanced Breast Cancer
10天前
已完结
Homologous recombination repair gene alteration is strongly associated with more prostate-specific membrane antigen-positive metastases in newly diagnosed hormone-sensitive prostate cancer with ≤5 conventional imaging defined distant metastases
1个月前
已完结
Genomic characterization of metastatic castration‐resistant prostate cancer patients undergoing PSMA radioligand therapy: A single‐center experience
1个月前
已完结
Pathogenic Genomic Alterations in Circulating Tumor DNA Predict Overall Survival in Men with Metastatic Castrate-resistant Prostate Cancer
1个月前
已完结
Integration of PSMA-Targeted Theranostics into Multidisciplinary Care for Improved Efficiencies and Patient Care
2个月前
已完结
A Deep Prostate-specific Antigen Response to Darolutamide plus Androgen Deprivation Therapy Is Associated with Better Clinical Outcomes in the Phase 3 ARANOTE Trial in Patients with Metastatic Hormone-sensitive Prostate Cancer
2个月前
已完结
First-in-human results of terbium-161 [161Tb]Tb-PSMA-I&T dual beta–Auger radioligand therapy in patients with metastatic castration-resistant prostate cancer (VIOLET): a single-centre, single-arm, phase 1/2 study
2个月前
已完结
皖公网安备34019202002308
